» Decreto-Lei n.º 52/2020 - Estabelece o responsável pelo tratamento dos dados e regula a intervenção do médico no sistema STAYAWAY COVID
» covid19.min-saude.pt
» Normas e Circulares Normativas
» Norma nº 004/2020 de 23/03/2020, atualizada a 25/04/2020, sobre a abordagem do Doente com Suspeita ou Infeção por SARS-CoV-2.
» EMCDDA documentation centre information bulletin - 16-07-21
» EMCDDA documentation centre information bulletin - 09-07-21
» EMCDDA documentation centre information bulletin - 02-07-21
» EMCDDA documentation centre information bulletin - 25-06-21
» EMCDDA documentation centre information bulletin - 18-06-21
» EMCDDA documentation centre information bulletin - 11-06-21
» EMCDDA documentation centre information bulletin - 04-06-21
» EMCDDA documentation centre information bulletin - 28-05-21
» EMCDDA documentation centre information bulletin - 21-05-21
» EMCDDA documentation centre information bulletin - 14-05-21
» EMCDDA documentation centre information bulletin - 07-05-21
» EMCDDA documentation centre information bulletin - 30-04-21
» EMCDDA documentation centre information bulletin - 23-04-21
» EMCDDA documentation centre information bulletin - 16-04-21
» EMCDDA documentation centre information bulletin - 09-04-21
» EMCDDA documentation centre information bulletin - 02-04-21
» EMCDDA documentation centre information bulletin - 26-03-21
» EMCDDA documentation centre information bulletin - 19-03-21
» EMCDDA documentation centre information bulletin - 12-03-21
» EMCDDA documentation centre information bulletin - 05-03-21
» EMCDDA documentation centre information bulletin - 26-02-21
» EMCDDA documentation centre information bulletin -19-02-21
» EMCDDA documentation centre information bulletin -12-02-21
» EMCDDA documentation centre information bulletin - 29-01-2021
» EMCDDA documentation centre information bulletin - 22-01-2021
» EMCDDA documentation centre information bulletin - 15-01-2021
» EMCDDA documentation centre information bulletin - 08-01-2021
» New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic — an update from the EU Early Warning
» EMCDDA documentationcentre information bulletin - 18-12-2020
» EMCDDA documentationcentre information bulletin - 11-12-2020
» EMCDDA documentationcentre information bulletin - 04-12-2020
» EMCDDA documentationcentre information bulletin - 27-11-2020
» EMCDDA documentationcentre information bulletin - 20-11-2020
» EMCDDA documentationcentre information bulletin - 13-11-2020
» EMCDDA documentationcentre information bulletin - 30-10-2020
» EMCDDA documentationcentre information bulletin - 23-10-2020
» EMCDDA documentationcentre information bulletin - 16-10-2020
» EMCDDA documentationcentre information bulletin - 09-10-2020
» EMCDDA documentationcentre information bulletin - 25-09-2020
» EMCDDA documentationcentre information bulletin - 18-09-2020
» EMCDDA documentationcentre information bulletin - 11-09-2020
» EMCDDA documentationcentre information bulletin - 28-08-2020
» EMCDDA documentationcentre information bulletin - 21-08-2020
» EMCDDA documentationcentre information bulletin - 07-08-2020
» EMCDDA documentationcentre information bulletin - 24-07-2020
» EMCDDA documentationcentre information bulletin - 17-07-2020
» Impacto do COVID-19 nos padrões de consumo de drogas e nos danos relacionados na Europa (en)
» Mercado de drogas na UE e o impacto da COVID-19 (en)
O Observatório Europeu da Droga e Toxicodependência disponibiliza um exercício de avaliação da situação no que respeita ao impacto da COVID 19 nos serviços e no apoio aos consumidores problemáticos de drogas: » Impacto da COVID-19 nas estruturas de apoio aos consumidores de droga (en)
» COVID-19 e pessoas que usam drogas
» Direitos sociais e comportamentos aditivos
» Medidas específicas para pessoas em situação sem-abrigo.pdf
» Resposta de Portugal à COVID-19. Não paramos. Estamos ON.
» Practice guidance for COVID-19
» asam.org/Quality-Science/covid-19-coronavirus
» naatp.org/covid-19-resources
» Guidance for the public on the mental health and wellbeing aspects of coronavirus (COVID-19) (atualizado a 25 de junho de 2020)
» Hébergement confiné et consommation d’alcool des publics (fr)
» COVID-19, tabaco, álcool e drogas: riscos e precauções (fr)
» COVID-19 e prescritores de produtos contendo buprenorfina em ambientes de tratamento com opióides em consultório (en)
Review Paper: » COVID-19 and substance use disorders: recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine(ISAM) Practice and Policy Interest Group Position Paper.
» Riscos de consumidores problemáticos (en)
» What to know about HIV and COVID-19
» Coronavirus disease (COVID-19) - UNODC updates
» Suggestions about treatment, care and rehabilitation of people with drugs use disorder in the context of the COVID-19
COVID-19 HIV prevention, treatment, care and support for people who use drugs:» Infographic 1» Infographic 2» Infographic 3
» COVID-19 and the drug supply chain: from productions and trafficking to use
» COVID-19 and Human Rights: We are all in this together
» UNODC, WHO, UNAIDS and other Join Statement on COVI-19 in prisons and other closed settings
» Declaração sobre os direitos das pessoas que usam drogas (en)
IN-Mouraria » Serviços disponíveis e horários no contexto da pandemia da doença COVID-19
O Grupo Pompidou lançou a plataforma » Save Lives - Protect People, que contém recomendações práticas para conter a disseminação do COVID-19 e evitar danos aos dependentes de drogas e aos que estão em contacto com este grupo de risco.
COVID-19 AND PEOPLE WHO USE DRUGS
Orientação da UE » De volta ao trabalho: Adaptar os locais de trabalho e proteger os trabalhadores (en)
» Public health messaging and harm reduction in the time of COVID-19
» Guia prático de perguntas frequentes sobre saúde sexual e covid-19
» Preparedness, prevention and control of COVID-19 in prisons and other places of detention: interim guidance
» Mitos sobre COVID-19: Coronavirus disease (COVID-19) advice for the public: Myth busters
» As respostas COVID-19 devem defender e proteger os direitos humanos dos profissionais do sexo (en)
» HIV e COVID-19 o que precisa de saber (en)
» COVID-19 Poses Unique Challenges For Alcohol Drinkers
» O Vírus não discrimina mas os seus impactos discriminam. Desigualdade no acesso aos cuidados de saúde às pessoas com HIV e aos consumidores de droga (en)
» Bibliography on COVID-19 and Addiction
» Preliminary overview of city measures to mitigate the socio-economic impact of COVID-19. Policy note, 4 May 2020
» Overview of social measures in cities to respond to COVID-19 crisis. Policy note, April 2020
» AFEW International Report